Wolverine Trading, LLC Viking Therapeutics, Inc. Transaction History

Wolverine Trading, LLC

$96.9 Billion
Q2 2025

A detailed history of Wolverine Trading, LLC transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Wolverine Trading, LLC holds 43,819 shares of VKTX stock, worth $1.55 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

43,819

Previous 64,095 31.63%

Holding current value

$1.55 Million

Previous $1.55 Million 24.95%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 18, 2025	SELL	$19.98 - $29.49 $405,114 - $597,939	-20,276 Reduced 31.63%	43,819 $1.16 Million
Q1 2025 May 15, 2025	BUY	$24.15 - $42.89 $394,297 - $700,265	16,327 Added 34.18%	64,095 $1.55 Million
Q4 2024 Feb 14, 2025	SELL	$38.28 - $78.03 $296,402 - $604,186	-7,743 Reduced 13.95%	47,768 $1.92 Million
Q3 2024 Nov 14, 2024	BUY	$49.84 - $70.47 $1.87 Million - $2.64 Million	37,462 Added 207.56%	55,511 $3.51 Million
Q2 2024 Aug 14, 2024	SELL	$47.39 - $80.2 $138,615 - $234,585	-2,925 Reduced 13.95%	18,049 $956,000
Q1 2024 May 15, 2024	BUY	$17.4 - $94.5 $170,311 - $924,966	9,788 Added 87.5%	20,974 $1.72 Million
Q4 2023 Feb 14, 2024	SELL	$9.24 - $19.64 $260,909 - $554,574	-28,237 Reduced 71.63%	11,186 $208,000
Q3 2023 Nov 15, 2023	SELL	$10.92 - $16.0 $1.23 Million - $1.8 Million	-112,383 Reduced 74.03%	39,423 $436,000
Q2 2023 Aug 23, 2023	SELL	$14.84 - $24.79 $184,861 - $308,809	-12,457 Reduced 7.58%	151,806 $2.46 Million
Q1 2023 May 15, 2023	BUY	$8.08 - $17.33 $1.04 Million - $2.22 Million	128,120 Added 354.48%	164,263 $2.85 Million
Q4 2022 Feb 14, 2023	BUY	$2.72 - $9.4 $98,308 - $339,744	36,143 New	36,143 $340,000
Q4 2021 Feb 14, 2022	SELL	$4.6 - $6.72 $66,079 - $96,532	-14,365 Reduced 46.92%	16,250 $75,000
Q1 2020 May 11, 2020	BUY	$3.45 - $7.95 $105,621 - $243,389	30,615 New	30,615 $145,000
Q1 2019 May 15, 2019	SELL	$7.58 - $9.94 $316,646 - $415,233	-41,774 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$7.16 - $16.21 $189,281 - $428,527	-26,436 Reduced 38.76%	41,774 $316,000
Q3 2018 Nov 14, 2018	BUY	$9.7 - $19.65 $661,637 - $1.34 Million	68,210 New	68,210 $1.19 Million

Others Institutions Holding VKTX

# of Institutions

455

Shares Held

67.9M

Call Options Held

7.72M

Put Options Held

3.31M

View Full List

About Viking Therapeutics, Inc.

Ticker VKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,688,496
Market Cap $2.71B
Description
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...

More about VKTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Account

Wolverine Trading, LLC Viking Therapeutics, Inc. Transaction History